Correlation Engine 2.0
Clear Search sequence regions

  • humans (1)
  • lipids (1)
  • nucleic acids (1)
  • products (12)
  • protocol (1)
  • receptor (2)
  • sugar (2)
  • Sizes of these terms reflect their relevance to your search.

    Chronic elevation of sugar and oxidative stress generally results in development of advanced glycation end products (AGEs) in diabetic individuals. Accumulation of AGEs in an individual can give rise to the activation of several pathways that will ultimately lead to various complications. Such AGEs can also be prepared in an in vitro environment. For an in vitro preparation of advanced glycation end products (AGEs), proteins, lipids, or nucleic acids are generally required to be incubated with reducing sugars at a physiological temperature or higher depending upon the protocol optimized for its preparation. Certain other factors are also optimized and added to the buffer to hasten its preparation or alter the properties of prepared AGEs. Through this review, we intend to highlight the various studies related to the experimental procedures for the preparation of different types of AGEs. In addition, we present the comparative study of methodologies optimized for the preparation of AGEs. © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.


    Ajay Kumar Sahi, Pooja Verma, Neelima Varshney, Shravanya Gundu, Sanjeev Kumar Mahto. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products. Applied biochemistry and biotechnology. 2022 Jun;194(6):2831-2855

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35257316

    View Full Text